Synthetic antimalarial tablets used for uncomplicated Plasmodium vivax and falciparum infections in susceptible strains. Employed in primary care settings and community health programs in low-transmission areas. Acquired by NGOs, national health ministries, and drug distributors for standard therapy protocols.